China proposes to involve police and media in unannounced drug inspections
This article was originally published in SRA
The deadline is nearing for pharmaceutical companies to comment on China's proposal to implement more extensive measures for carrying out unannounced drug inspections that would involve, in certain cases, the involvement of the police and news media1.
You may also be interested in...
Alnylam’s Givlaari for acute hepatic porphyria is also among the 14 new products that could get an EU approval recommendation this week.
Uncertainties over clinical and cost effectiveness are behind the health technology assessment body’s recommendation against Spravato's use on the National Health Service.
New medicines under evaluation at the European Medicines Agency.